Skip to main content

Table 1 Comparison of demographic and medical characteristics of the two study groups in the ITT population

From: Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial

 

Diclegis (n-131)

Placebo (n = 125)

P-value

Ethnicity:

  

0.48

Hispanic or Latino

53 (40.5%)

56 (44.8%)

 

Not Hispanic or Latino

78 (59.5%)

69 (55.2%)

 

Race:

  

0.59

Asian

2 (1.5%)

1 (0.8%)

 

Black or African American

49 (37.4%)

48 (38.4%)

 

White or Caucasian

80 (61.1%)

73 (58.4%)

 

Unknown

 

3 (2.4%)

 

Previous Pregnancy

101 (77.1%)

94 (75.2%)

0.64

Smoking during pregnancy

17 (13.0%)

16 (12.8%)

0.97

Maternal Age (yr)

25.9 ± 6

25.0 ± 5.7

0.23

Weight (kg)

74.10 ± 22.30

75.91 ± 22.19

0.50

(lbs)

163.35 ± 49.17

167.34 ± 48.91

0.50

BMI (kg/m2):

  

0.42

Underweight

5 (3.8%)

4 (3.2%)

 

Normal

39 (29.8%)

38 (30.4%)

 

Overweight

31 (23.7%)

40 (32.0%)

 

Obese

55 (42.0%)

42 (33.6%)

 

BMI (kg/m2)

  

0.95

Mean ± SD

28.77 ± 7.60

29.67 ± 11.20

 

Median

27.97

26.83

 

Gestational age at start of NVP (weeks)

  

0.90

Mean ± SD

5.5 ± 1.8

5.4 ± 1.7

 

Gestational age at enrollment (weeks)

  

0.75

Mean ± SD

9.3 ± 2.0

9.3 ± 1.8

 

PUQE score at Enrollment

  

0.44

Mean ± SD

9.0 ± 2.1

8.8 ± 2.1

 

Median

9.0

8.0

 

Global Assessment of Well Being

   

Mean ± SD

5.0 ± 2.3

5.4 ± 2.2

 

Median

5.0

5.0